These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
69 related articles for article (PubMed ID: 3052828)
1. A morphological analysis of an in vitro model of cytotoxic antitumor activity. Bielat KL; Halpern J; Simich JP; Huben RP; Ambrus JL Cancer Detect Prev; 1988; 12(1-6):1-7. PubMed ID: 3052828 [TBL] [Abstract][Full Text] [Related]
2. Human peripheral blood mononuclear cells (PBM) cultured in serum-free medium. III. Morphological study of an in vitro microcytotoxicity model. Halpern J; Bielat KL; Simich JP; Klein E; Ambrus JL J Med; 1986; 17(3-4):201-18. PubMed ID: 3295091 [TBL] [Abstract][Full Text] [Related]
3. Ultrastructural descriptions of interactions between tumor-infiltrating lymphocytes and tumor cells in an in vitro model of culture in serum-free medium. Halpern JN; Bielat KL; Simich JP; Ambrus JL Cancer Detect Prev; 1988; 13(3-4):213-23. PubMed ID: 3242828 [TBL] [Abstract][Full Text] [Related]
4. IL-2 enhances standard IFNgamma/LPS activation of macrophage cytotoxicity to human ovarian carcinoma in vitro: a potential for adoptive cellular immunotherapy. Han X; Wilbanks GD; Devaja O; Ruperelia V; Raju KS Gynecol Oncol; 1999 Nov; 75(2):198-210. PubMed ID: 10525372 [TBL] [Abstract][Full Text] [Related]
5. In vitro induction of tumor-specific human lymphocyte antigen class I-restricted CD8 cytotoxic T lymphocytes by ovarian tumor antigen-pulsed autologous dendritic cells from patients with advanced ovarian cancer. Santin AD; Hermonat PL; Ravaggi A; Bellone S; Pecorelli S; Cannon MJ; Parham GP Am J Obstet Gynecol; 2000 Sep; 183(3):601-9. PubMed ID: 10992180 [TBL] [Abstract][Full Text] [Related]
6. Interleukin 2 expanded tumor-infiltrating lymphocytes in human renal cell cancer: isolation, characterization, and antitumor activity. Belldegrun A; Muul LM; Rosenberg SA Cancer Res; 1988 Jan; 48(1):206-14. PubMed ID: 3257161 [TBL] [Abstract][Full Text] [Related]
7. Tumor-infiltrating lymphocytes: in vitro characterization of morphological and phenotypical changes. Halpern J; Islam A; Simich JP; Piver MS; Ambrus JL; Bielat KL Cancer Detect Prev; 1988; 13(1):1-7. PubMed ID: 3265648 [TBL] [Abstract][Full Text] [Related]
8. Immunologic features of tumor-infiltrating lymphocytes and peripheral blood lymphocytes in ovarian cancer patients. Schöndorf T; Engel H; Kurbacher CM; Brenne U; Kolhagen H; Göhring UJ; Scharl A; Mallmann P J Soc Gynecol Investig; 1998; 5(2):102-7. PubMed ID: 9509389 [TBL] [Abstract][Full Text] [Related]
9. Interleukin 2 activation of cytotoxic T-lymphocytes infiltrating into human metastatic melanomas. Itoh K; Tilden AB; Balch CM Cancer Res; 1986 Jun; 46(6):3011-7. PubMed ID: 3486040 [TBL] [Abstract][Full Text] [Related]
10. Functional analysis of mononuclear cells infiltrating into tumors: lysis of autologous human tumor cells by cultured infiltrating lymphocytes. Rabinowich H; Cohen R; Bruderman I; Steiner Z; Klajman A Cancer Res; 1987 Jan; 47(1):173-7. PubMed ID: 3491673 [TBL] [Abstract][Full Text] [Related]
11. Interleukin-2 expanded lymphocytes from lymph node and tumor biopsies of human renal cell carcinoma, breast and ovarian cancer. Bouet-Toussaint F; Genetel N; Rioux-Leclercq N; Bansard JY; Levêque J; Guillé F; Patard JJ; Lesimple T; Catros-Quemener V Eur Cytokine Netw; 2000 Jun; 11(2):217-24. PubMed ID: 10903800 [TBL] [Abstract][Full Text] [Related]
12. In vivo antitumor activity of tumor-infiltrating lymphocytes expanded in recombinant interleukin-2. Spiess PJ; Yang JC; Rosenberg SA J Natl Cancer Inst; 1987 Nov; 79(5):1067-75. PubMed ID: 3500355 [TBL] [Abstract][Full Text] [Related]
13. Tumor lymphocytes in patients with advanced ovarian cancer: changes during in vitro culture and implications for immunotherapy. Han X; Papadopoulos AJ; Ruparelia V; Devaja O; Raju KS Gynecol Oncol; 1997 Jun; 65(3):391-8. PubMed ID: 9190963 [TBL] [Abstract][Full Text] [Related]
14. Immunosensitization of resistant human tumor cells to cytotoxicity by tumor infiltrating lymphocytes. Frost P; Caliliw R; Belldegrun A; Bonavida B Int J Oncol; 2003 Feb; 22(2):431-7. PubMed ID: 12527945 [TBL] [Abstract][Full Text] [Related]
15. T cell receptor V beta 2 and V beta 6 mediate tumor-specific cytotoxicity by tumor-infiltrating lymphocytes in ovarian cancer. Peoples GE; Davey MP; Goedegebuure PS; Schoof DD; Eberlein TJ J Immunol; 1993 Nov; 151(10):5472-80. PubMed ID: 8228239 [TBL] [Abstract][Full Text] [Related]
16. Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma. Freedman RS; Kudelka AP; Kavanagh JJ; Verschraegen C; Edwards CL; Nash M; Levy L; Atkinson EN; Zhang HZ; Melichar B; Patenia R; Templin S; Scott W; Platsoucas CD Clin Cancer Res; 2000 Jun; 6(6):2268-78. PubMed ID: 10873077 [TBL] [Abstract][Full Text] [Related]
17. A parathyroid-hormone-related-protein (PTH-rP)-specific cytotoxic T cell response induced by in vitro stimulation of tumour-infiltrating lymphocytes derived from prostate cancer metastases, with epitope peptide-loaded autologous dendritic cells and low-dose IL-2. Correale P; Micheli L; Vecchio MT; Sabatino M; Petrioli R; Pozzessere D; Marsili S; Giorgi G; Lozzi L; Neri P; Francini G Br J Cancer; 2001 Nov; 85(11):1722-30. PubMed ID: 11742494 [TBL] [Abstract][Full Text] [Related]
18. Differential sensitivity of tumor targets to liver macrophage-mediated cytotoxicity. Gardner CR; Wasserman AJ; Laskin DL Cancer Res; 1987 Dec; 47(24 Pt 1):6686-91. PubMed ID: 3119198 [TBL] [Abstract][Full Text] [Related]
19. Adoptive cellular immunotherapy of human ovarian carcinoma xenografts in nude mice. Ortaldo JR; Porter HR; Miller P; Stevenson HC; Ozols RF; Hamilton TC Cancer Res; 1986 Sep; 46(9):4414-9. PubMed ID: 3089592 [TBL] [Abstract][Full Text] [Related]
20. An ultrastructural analysis of lympho-reticular cell interactions in primary cultures of human non-lymphoid neoplasms and lymphomas. Underwood JC J Pathol; 1976 Oct; 120(2):75-82. PubMed ID: 789836 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]